These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 8829443)

  • 1. [Dopaminergic mechanisms in the immunostimulating effect of mu-opioid receptors].
    Cheĭdo MA; Idova GV
    Biull Eksp Biol Med; 1996 Apr; 121(4):373-5. PubMed ID: 8829443
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence for a role of dopaminergic mechanisms in the immunostimulating effect of mu-opioid receptor agonist DAGO.
    Devoino L; Cheido M; Alperina E; Idova G
    Int J Neurosci; 2003 Oct; 113(10):1381-94. PubMed ID: 14534037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A; Sorrentino L
    Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Differential contribution of dopamine D1 and D2 receptors in the mu-opioidergic immunomodulation].
    Cheĭdo MA; Idova GV
    Ross Fiziol Zh Im I M Sechenova; 2006 May; 92(5):546-51. PubMed ID: 16869283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of opioid peptides on immunomodulation].
    Cheĭdo MA; Idova GV
    Ross Fiziol Zh Im I M Sechenova; 1998 Apr; 84(4):385-90. PubMed ID: 9742618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of dopaminergic mechanism in the realization of immunostimulating effect of substance P and its analog].
    Cheĭdo MA
    Biull Eksp Biol Med; 1997 Feb; 123(2):135-7. PubMed ID: 9280479
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cardioprotective effects of stimulation of peripheral mu-opiate receptors, and the role of opiatergic mechanisms in the pathogenesis of stress-induced heart damage].
    Lishmanov IuB; Maslov LN; Naryzhnaia NV
    Biull Eksp Biol Med; 1997 Mar; 123(3):276-8. PubMed ID: 9162233
    [No Abstract]   [Full Text] [Related]  

  • 8. [Participation of the dopaminergic system in the immune response-stimulating effect of muramyl dipeptide].
    Al'perina EL; Zidek Z; Idova GV; Devoĭno LV
    Biull Eksp Biol Med; 1988 Aug; 106(8):198-200. PubMed ID: 3416056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
    He L; Lee NM
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Opiate-ergic mechanisms of the cardiotropic effect of acute cooling].
    Afanas'ev SA; Alekseeva ED; Lishmanov IuB
    Biull Eksp Biol Med; 1994 Dec; 118(12):582-4. PubMed ID: 7703448
    [No Abstract]   [Full Text] [Related]  

  • 11. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The differential contribution of dopamine D(1) and D (2) receptors to mu-opioidergic immunomodulation.
    Cheido MA; Idova GV
    Neurosci Behav Physiol; 2007 Sep; 37(7):721-4. PubMed ID: 17763992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mu-opioidergic immunomodulation: the neurochemical basis].
    Cheĭdo MA; Idova GV
    Usp Fiziol Nauk; 2009; 40(2):12-25. PubMed ID: 19505020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Modulating effect of mu-opioid receptor ligands on adrenergic mechanism of stressor heart damage pathogenesis].
    Lishmanov IuB; Naryzhnaia NV; Revinskaia IuG; Maslov LN
    Biull Eksp Biol Med; 1998 Nov; 126(11):510-2. PubMed ID: 9883355
    [No Abstract]   [Full Text] [Related]  

  • 15. Agonist-induced functional desensitization of the mu-opioid receptor is mediated by loss of membrane receptors rather than uncoupling from G protein.
    Pak Y; Kouvelas A; Scheideler MA; Rasmussen J; O'Dowd BF; George SR
    Mol Pharmacol; 1996 Nov; 50(5):1214-22. PubMed ID: 8913353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of opiate receptor ligands on the morpho-functional state of the sympathico-adrenal system and electrical stability of the heart in acute exposure to cold].
    Lishmanov IuB; Kondrat'ev BIu; Maslov LN; Naryzhnaia NV
    Biull Eksp Biol Med; 1997 Feb; 123(2):154-7. PubMed ID: 9280484
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of intracerebroventricular administration of beta-funaltrexamine on DAMGO-stimulated [35S]GTP-gamma-S binding in rat brain sections.
    Martin TJ; Sim LJ; Selley DE; deMontis MG; Childers SR
    Synapse; 1997 Nov; 27(3):177-82. PubMed ID: 9329153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shell/core differences in mu- and delta-opioid receptor modulation of dopamine efflux in nucleus accumbens.
    Hipólito L; Sánchez-Catalán MJ; Zanolini I; Polache A; Granero L
    Neuropharmacology; 2008 Aug; 55(2):183-9. PubMed ID: 18582908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics of effects of mu-, delta-, and kappa-opioid agonists and enkephalinase inhibitor RB101 in rats of two inbred strains].
    Sudakov SK; Liupina IuV; Medvedeva OF; Tiurina IV; Maldonado R
    Biull Eksp Biol Med; 1998 May; 125(5):551-4. PubMed ID: 9644557
    [No Abstract]   [Full Text] [Related]  

  • 20. [The role of the vagus nerve in the anti-arrhythmic effect of DAGO in acute myocardial ischemia].
    Mikhaĭlova SD; Storozhakov GI; Bebiakova NA; Semushkina TM
    Biull Eksp Biol Med; 1997 Oct; 124(10):377-9. PubMed ID: 9410162
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.